Nightly News   |  December 28, 2011

Avastin could buy time in battle with ovarian cancer

Two studies out Wednesday show that Avastin, a drug that is already approved for other cancers -- but is also controversial -- could help women buy more time in the battle with ovarian cancer. More from NBC's Chief Science Correspondent Robert Bazell.

Share This:

Sorry, we do not have a transcript available for this video at this time.